FDA Approves "Investigational New Drug" Application for Cannabis In Migraine Treatment
marijuananews.comPress release on FDA approval for Ethan Russo, MD, a neurologist in Missoula, Montana, to study the effects of smoked cannabis (marijuana) as compared to oral dronabinol (Marinol®) and injected sumatriptan (Imitrex®- the current "gold standard") in the acute treatment of migraine.
Rate This Site
Embed Badge
Place this code on your website to show you're listed here.